The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Open accessAbstract
FGF-23, a novel member of the FGF family, is the product of the gene mutated in autosomal dominant hypophosphatemic rickets (ADHR). FGF-23 has been proposed as a circulating factor causing renal phosphate wasting not only in ADHR (as a result of inadequate degradation), but also in tumor-induced osteomalacia (as a result of excess synthesis by tumor cells). Renal phosphate wasting occurs in approximately 50% of patients with McCune-Albright syndrome (MAS) and fibrous dysplasia of bone (FD), which result from postzygotic mutations of the GNAS1 gene. We found that FGF-23 is produced by normal and FD osteoprogenitors and bone-forming cells in vivo and in vitro. In situ hybridization analysis of FGF-23 mRNA expression identified "fibrous" cells, osteogenic cells, and cells associated with microvascular walls as specific cellular sources of FGF-23 in FD. Serum levels of FGF-23 were increased in FD/MAS patients compared with normal age-matched controls and significantly higher in FD/MAS patients with renal phosphate wasting compared with those without, and correlated with disease burden bone turnover markers commonly used to assess disease activity. Production of FGF-23 by FD tissue may play an important role in the renal phosphate-wasting syndrome associated with FD/MAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
Weinstein, L. S., Shenker, A., Gejman, P. V., Merino, M. J., Friedman, E., & Spiegel, A. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252403 · Cited by 1,691
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Self-citationCloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Self-citationAlbright, F., Butler, A. M., Hampton, A. O., et al. (1937) · New England Journal of Medicine · doi:10.1056/nejm193704292161701 · Cited by 1,057
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
Self-citationBrodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Kuznetsov, S. A., Krebsbach, P. H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., & Robey, P. G. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1335 · Cited by 723
Self-citationRobey, P. G., & Termine, J. D. (1985) · Calcified Tissue International · doi:10.1007/bf02557826 · Cited by 694
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
White, K. E., Carn, G., Lorenz-Depiereux, B., Benet-Pages, A., Strom, T. M., & Econs, M. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00064.x · Cited by 493
Self-citationShimada, T. (2002) · Endocrinology · doi:10.1210/en.143.8.3179 · Cited by 446
Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins
Fisher, L. W., Stubbs, J. T., & Young, M. F. (1995) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679509157649 · Cited by 443
MEPE, a New Gene Expressed in Bone Marrow and Tumors Causing Osteomalacia
Rowe, P. S. N., de Zoysa, P. A., Dong, R., Wang, H. R., White, K. E., Econs, M. J., & Oudet, C. L. (2000) · Genomics · doi:10.1006/geno.2000.6235 · Cited by 363
Self-citationWhite, K. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.497 · Cited by 329
Self-citationBianco, P., Riminucci, M., Majolagbe, A., Kuznetsov, S. A., Collins, M. T., Mankani, M. H., Corsi, A., Bone, H. G., Wientroub, S., Spiegel, A. M., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.120 · Cited by 269
Self-citationFibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.
Riminucci, M., Fisher, L. W., Shenker, A., Spiegel, A. M., Bianco, P., & Robey, P. G. (1997) · Europe PMC (PubMed Central) · Cited by 225
Self-citationBianco, P., Kuznetsov, S. A., Riminucci, M., Fisher, L. W., Spiegel, A. M., & Robey, P. G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2361 · Cited by 225
Self-citationTumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism
De Beur, S. M. J., Finnegan, R. B., Vassiliadis, J., Cook, B., Barberio, D., Estes, S., Manavalan, P., Petroziello, J., Madden, S. L., Cho, J. Y., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1102 · Cited by 212
Collins, M. T., Chebli, C., Jones, J., Kushner, H., Consugar, M., Rinaldo, P., Wientroub, S., Bianco, P., & Robey, P. G. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.5.806 · Cited by 189
Self-citationRenal Tubular Reabsorption of Phosphate (TmP/GFR): Indications and Interpretation
Payne, R. B. (1998) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329803500203 · Cited by 184
Tumor-induced osteomalacia and the regulation of phosphate homeostasis
Kumar, R. (2000) · Bone · doi:10.1016/s8756-3282(00)00334-3 · Cited by 149
TESTS OF PHOSPHATE REABSORPTION
Kenny, A. P., & Glen, A. C. A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93112-7 · Cited by 127
Oncogenic Osteomalacia — A Complex Dance of Factors
Carpenter, T. O. (2003) · New England Journal of Medicine · doi:10.1056/nejme030037 · Cited by 125
Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.
Wilkins, G. E., Granleese, S. R., Hegele, R. G., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745010 · Cited by 114
Hypophosphataemic Osteomalacia in Fibrous Dysplasia
Dent, C. E., & Gertner, J. M. (1976) · QJM · doi:10.1093/oxfordjournals.qjmed.a067471 · Cited by 88
FGF23, hypophosphatemia, and rickets: Has phosphatonin been found?
Strewler, G. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111154898 · Cited by 75
Fukumoto, S., & Yamashita, T. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200207000-00003 · Cited by 74
DISORDERS OF PHOSPHATE METABOLISM
DiMeglio, L. A., White, K. E., & Econs, M. J. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70152-3 · Cited by 48
Self-citation
Cited by
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Receptor Specificity of the Fibroblast Growth Factor Family
Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601252200 · Cited by 1,164
Metadata
- Authors
- Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S., Gupta, A., Hannon, T., Econs, M. J., Bianco, P., & Gehron Robey, P.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-09-01
- Volume
- 112
- Issue
- 5
- Pages
- 683-692
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2109177164
- Cited by
- 657
- References
- 29
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.